Zobrazeno 1 - 10
of 1 861
pro vyhledávání: '"S. Tura"'
Publikováno v:
The International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, Vol XLII-2-W11, Pp 353-357 (2019)
Inventory Project for the Cultural Assets of Istanbul (2015–2019) revealed that there are approximately 35000 historical and cultural assets in Istanbul due to its history with regards to being homeland and capital of many different civilizations.
Externí odkaz:
https://doaj.org/article/4d2bd38f085d4da290998fc2b6e47da0
Publikováno v:
The International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, Vol XLII-2-W11, Pp 353-357 (2019)
Inventory Project for the Cultural Assets of Istanbul (2015–2019) revealed that there are approximately 35000 historical and cultural assets in Istanbul due to its history with regards to being homeland and capital of many different civilizations.
Publikováno v:
Immuno-Oncology and Technology, Vol 19, Iss , Pp 100386- (2023)
Uveal melanoma (UM) is the most common ocular malignancy in adults, associated with the poorest prognosis, with metastatic disease occurring in up to 50% of patients. In contrast to metastatic cutaneous melanoma, the use of immune checkpoint inhibito
Externí odkaz:
https://doaj.org/article/e893d1c3de78405392325ceda0ad006e
Autor:
A. Lindeberg, M. T. Lint, C. Belanger, Michele Cavo, B. Simonsson, A. Toivanen, G. Lucarelli, S. Tura, G. Gahrton, J. Reiffers, J. P. Vernant, F. E. Zwaan, B Sallerfors, A Ferrant, Liisa Volin, J. L. Harrouseau, L. F. Verdonck, M. Gore, A. Gratwohl, B. Chapvis, O Ringdén, M. Michallet, Per Ljungman, M. Flesch, B. Löwenberg, P Gravett, X. Troussard
Publikováno v:
European Journal of Haematology. 43:182-185
50 patients with a median age of 41 years (range 29–54) underwent allogeneic bone marrow transplantation for multiple myeloma. 35 patients were on second-line treatment, and 15 on first-line treatment. 24 patients were considered refractory to prev
Publikováno v:
Immuno-Oncology and Technology, Vol 17, Iss , Pp 100373- (2023)
Externí odkaz:
https://doaj.org/article/afcd38f2aa0742c0a77007c972c155c0
Autor:
Myriam Labopin, L. Fouillard, O Ringdén, G. Ehninger, Laurent Garderet, Francesco Frassoni, Norbert-Claude Gorin, Emmanuelle Polge, S. Tura, Jürgen Finke
Publikováno v:
Bone Marrow Transplantation. 31:23-29
We analysed data for 213 patients with ALL and AML who received either peripheral blood stem cells (PBSC) (n=74) or bone marrow (BM) (n=139) from an HLA-matched unrelated donor (EBMT acute leukaemia registry; January 1994 to January 1999). The two gr
Autor:
Moshe Talpaz, Andreas Hochhaus, Anne L. Lennard, Richard T. Silver, Thomas M. Fischer, Sofia Fernandes-Reese, Insa Gathmann, Charles L. Sawyers, Michael W. Deininger, Hagop M. Kantarjian, Richard Stone, Charles A. Schiffer, John M. Goldman, François Xavier Mahon, Oliver G. Ottmann, S Tura, Francois Guilhot, Renaud Capdeville, Brian J. Druker, Michele Baccarani, A Gratwohl, Carlo Gambacorti-Passerini
Publikováno v:
Blood. 99:1928-1937
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine kinase oncogene, the product of the t(9;22) Philadelphia translocation. Patients with CML in accelerated phase have rapidly progressive disease and are characteristica
Autor:
G, Gahrton, H, Svensson, M, Cavo, J, Apperly, A, Bacigalupo, B, Björkstrand, J, Bladé, J, Cornelissen, A, de Laurenzi, T, Facon, P, Ljungman, M, Michallet, D, Niederwieser, R, Powles, J, Reiffers, N H, Russell, D, Samson, U W, Schaefer, A, Schattenberg, S, Tura, L F, Verdonck, J P, Vernant, R, Willemze, L, Volin
Publikováno v:
British Journal of Haematology, 113, 1, pp. 209--16
British Journal of Haematology, 113, 209--16
British Journal of Haematology, 113, 209--16
Item does not contain fulltext Out of 690 allogeneic matched sibling donor transplants for multiple myeloma reported to the European Group for Blood and Marrow Transplantation (EBMT) registry, 334 were performed during the period 1983-93 (all with bo
Autor:
P. Mazza, S. Tura, M. Bocchia, P. L. Zinzani, F. Gherlinzoni, F. Mandelli, M. P. Anselmo, G. Papa, M. Antimi, P. G. Gobbi, A. Porcellini, V. Rizzoli, L. Resegotti, A. Levis, L. Deriu, A. Chierichini, F. Ciccone, R. Fanin, G. Castoldi, G. L. Scapoli, V. Liso, T. Chisesi, L. Rancan, B. Amurri
Publikováno v:
European Journal of Haematology. 45:22-24
In an ongoing phase II study we are evaluating the role of alpha-2b recombinant interferon in Hodgkin's disease; the study design includes patients with high-risk parameters who are treated by combination chemotherapy MOPP, ABVD, MOPP + ABVD or equiv